Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Cytokine & Growth Factor Reviews
|
May 8, 2014
Letter to the editor on "Demoulin JB, Essaghir A. PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev (2014)"
M P Keasey, J R M Oliveira
Lupus
|
October 20, 2018
The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review
E Peterknecht, M P Keasey, M W Beresford
Scientific Reports
|
May 18, 2016
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1
M P Keasey, R R Lemos, T Hagg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 10, 2017
Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease
J L Howarth, S Kelly, M P Keasey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 12, 2007
Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease
J L Howarth, S Kelly, M P Keasey, et al.
Journal of Molecular Neuroscience : MN
|
June 28, 2014
First report of a de novo mutation at SLC20A2 in a patient with brain calcification
J B Ferreira, L Pimentel, M P Keasey, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Cytokine & Growth Factor Reviews
|
May 8, 2014
Letter to the editor on "Demoulin JB, Essaghir A. PDGF receptor signaling networks in normal and cancer cells. Cytokine Growth Factor Rev (2014)"
M P Keasey, J R M Oliveira
Lupus
|
October 20, 2018
The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review
E Peterknecht, M P Keasey, M W Beresford
Scientific Reports
|
May 18, 2016
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1
M P Keasey, R R Lemos, T Hagg, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 10, 2017
Hsp40 Molecules That Target to the Ubiquitin-proteasome System Decrease Inclusion Formation in Models of Polyglutamine Disease
J L Howarth, S Kelly, M P Keasey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 12, 2007
Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease
J L Howarth, S Kelly, M P Keasey, et al.
Journal of Molecular Neuroscience : MN
|
June 28, 2014
First report of a de novo mutation at SLC20A2 in a patient with brain calcification
J B Ferreira, L Pimentel, M P Keasey, et al.
Page
of 1